Oil and gas are on the rise, uranium demand is ever-increasing, and renewable energy isn’t always what it’s cracked up to be. But how can investors balance their portfolio and invest in the future of energy? Click here to access the full Thematic Insights investor report.

In this edition of Thematic Insights, formerly known as Thematica, business writer and analyst Jeff Nielson provides an outlook into the green energy market, highlighting the following:

  • The importance of oil and gas: Acknowledging that fossil fuels are still integral to energy and the economy.
  • Renewable energy: is it really green? What the path towards clean and green energy actually looks like.
  • Is nuclear energy about to explode: Understanding that nuclear power isn’t just about nuclear disasters but is integral to the future of energy.
  • Energy Stocks: Dive into enduring value for those seeking leverage.
  • A fine balancing act: Achieving climate change goals with an even-keeled energy strategy.

In tandem with the breakdown of the current landscape of the green energy market and the many ways to invest, Jocelyn Aspa, markets reporter with The Market Online, breaks down seven companies with massive upside potential that might pique the interest of investors.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online
Air Canada airliner

Air Canada negotiates new labour deal with pilots, avoids shutdown

Air Canada (TSX:AC) and the union representing thousands of its pilots negotiated a new labour deal and averted a nationwide shutdown.
Tudor Gold 2020 drilling at Treaty Creek.

Tudor Gold to advance Treaty Creek Project with Fuse Advisors

Tudor Gold (TSXV:TUD) enters into an agreement with Fuse Advisors to advance the Treaty Creek Project in British Columbia's Golden Triangle.
U.S. Food and Drug website in browser with logo

FDA extends review period for Medexus’ treosulfan to 2025

Medexus Pharmaceuticals (TSX:MDP) reveals the U.S. FDA has extended the review period for the company's new drug application for treosulfan.
King's Cross station in London

AtkinsRéalis boosts long-term revenue with U.K. rail contract

AtkinsRéalis Group (TSX:ATRL) will modernize the U.K.'s rail signalling infrastructure over the next decade.